BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Queensland Health
Argus Health
Harvard Business School
Deloitte
Merck
Baxter
Cantor Fitzgerald
Chinese Patent Office
US Army

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,110,706

« Back to Dashboard

Which drugs does patent 8,110,706 protect, and when does it expire?

Patent 8,110,706 protects BROVANA and is included in one NDA.

This patent has thirteen patent family members in twelve countries.
Summary for Patent: 8,110,706
Title:Formoterol tartrate process and polymorph
Abstract: A method of preparation of a highly pure salt of R,R-formoterol L-tartrate is disclosed. The process provides the most thermodynamically stable polymorph by recrystallization of a novel polymorph.
Inventor(s): Tanoury; Gerald J. (Hudson, MA), Senanayake; Chris H. (Brookfield, CT), Kessler; Donald W. (Groton, MA)
Assignee: Sunovion Pharmaceuticals Inc. (Marlborough, MA)
Application Number:12/767,043
Patent Claim Types:
see list of patent claims
Composition; Compound; Delivery; Dosage form;

Drugs Protected by US Patent 8,110,706

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Sunovion BROVANA arformoterol tartrate SOLUTION;INHALATION 021912-001 Oct 6, 2006 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,110,706

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,479,572 Formoterol tartrate process and polymorph ➤ Subscribe
6,472,563 Formoterol tartrate process and polymorph ➤ Subscribe
6,720,453 Formoterol tartrate polymorph ➤ Subscribe
7,732,641 Formoterol tartrate process and polymorph ➤ Subscribe
7,342,132 Formoterol tartrate process and polymorph ➤ Subscribe
7,145,036 Formoterol tartrate polymorph ➤ Subscribe
7,964,753 Formoterol tartrate process and polymorph ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,110,706

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Slovenia 1446380 ➤ Subscribe
Portugal 1446380 ➤ Subscribe
Japan 4271574 ➤ Subscribe
Japan 2005509025 ➤ Subscribe
Spain 2336436 ➤ Subscribe
European Patent Office 2305635 ➤ Subscribe
European Patent Office 2165999 ➤ Subscribe
European Patent Office 1446380 ➤ Subscribe
Denmark 1446380 ➤ Subscribe
Germany 60234629 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Accenture
Covington
QuintilesIMS
Chubb
US Department of Justice
Julphar
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot